In today’s briefing:
- Good Morning Japan |SPX Gains; TSMC to Cut Capex; NUGGET: Nissan – Costly Decisions ?
- The Innovations Portfolios – Week Twenty One
- China Biotech – The Commercialization Performance and The Outlook
- The Highlights : Cannabis News for the Week Ending April 14, 2023
- Weekly Sustainable Investing Surveyor : Week Ended April 14, 2023
Good Morning Japan |SPX Gains; TSMC to Cut Capex; NUGGET: Nissan – Costly Decisions ?
- OVERSEAS. SPX closes with gains, Financials and Industrials lead; TSMC to cut capex – hits global SPE stocks; Samsung to (partially) abondon Google ?
- JAPAN. NKY Futs +0.3% vs Cash; USDJPY 134.5 as new Gov Ueda says he will stay the (dovish) course; Activists sharpen knives ahead of Japan AGM season
- NUGGET. Nissan decouples from Renault- but at what cost ?
The Innovations Portfolios – Week Twenty One
- The three companies we write about this week are CATL (A) (300750 CH) , Kimberly Clark (KMB US) and BlackBerry Ltd (BB CN)
- For the twenty-one weeks since inception ended 14 April the combined innovation portfolio was +3.6%, versus DJIA +0.4%, S&P500 +4.3%, Nasdaq +8.8%, Russell2000 -3.7%, MSCI-ACWI-ETF +6.2%, all in US$ terms
- For the same period the small cap innovation portfolio was up +5.9%, the mid cap portfolio was up +4.4% and the large cap portfolio was up +3.4%
China Biotech – The Commercialization Performance and The Outlook
- It is the time to reassess the commercialization performance and the outlook of China biotech companies, including BeiGene, Innovent, Henlus, Zai Lab, Hutchmed, Junshi, RemeGen, Innocare, Akeso.
- We summarized the data of these biotech companies’ product revenue and profit performance to judge whether their commercialization capability is sufficient to afford production, sales teams and long-term R&D activities.
- Most China Biotech cannot be said to achieve “commercialization success”, but they have showed some difference.We hope investors could have a better understanding about China biotech and make better decisions.
The Highlights : Cannabis News for the Week Ending April 14, 2023
- Broad equity indexes booked their fourth straight week of positive returns, with the MSCI World Index and the S&P 500 up 1.23% and 0.79%, respectively.
- Small caps followed suit, with the Russell 2000 gaining 1.48% this week.
- Cannabis stocks slid for the sixth straight week, with the MSOS ETF declining 0.56%. It was shaping up to be a good week until the MSOS ETF fell 3.97% on Friday.
Weekly Sustainable Investing Surveyor : Week Ended April 14, 2023
- WTR Sustainable Index: During the week ended April 14, 2023, the WTR Sustainable Index performed in line with the broader market, rising 1.0% W/W versus the S&P 500 Index (up 0.8%), the Russell 2000 Index (up 1.5%), and the Nasdaq Composite Index (up 0.3%).
- Energy Technology (8.0% of the index) drove the index performance, rising 4.7%, while Advanced Transportation Solutions (69.3% of the index) was up 0.1% and Industrial Climate and Ag Technology was up 2.7%.
- Valuation: Based on forward 12-month consensus estimates, the current P/E ratio of the WTR Sustainable index is 28.5x versus 18.9x for the S&P 500.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
